Useful tips

How long is induction therapy for AML?

How long is induction therapy for AML?

Standard remission induction therapy currently consists of 3 days of an anthracycline and 7 days of cytarabine. Following induction, patients typically require 2-3 weeks for bone marrow blood cell production to recover.

Can you live 20 years with AML?

The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people 20 and older with AML is 26%. For people younger than 20, the survival rate is 68%.

How is acute myeloid leukemia ( AML ) treated in adults?

Treating frail or older adults. Treatment of AML in people under 60 is fairly standard. It involves cycles of intensive chemo, sometimes along with a stem cell transplant (as discussed above). Many patients older than 60 are healthy enough to be treated in the same way, although sometimes the chemo may be less intense.

What happens when there are too many stem cells in AML?

Sometimes in AML, too many stem cells become abnormal red blood cells or platelets. These abnormal white blood cells, red blood cells, or platelets are also called leukemia cells or blasts. Leukemia cells can build up in the bone marrow and blood so there is less room for healthy white blood cells, red blood cells, and platelets.

How is consolidation used to treat acute myeloid leukemia?

Consolidation (post-remission therapy) Induction is considered successful if remission is achieved. Further treatment (called consolidation) is then given to try to destroy any remaining leukemia cells and help prevent a relapse. Consolidation for younger patients

When does acute promyelocytic leukemia occur in an adult?

Acute promyelocytic leukemia (APL) is a subtype of AML that occurs when parts of two genes stick together. APL usually occurs in middle-aged adults. Signs of APL may include both bleeding and forming blood clots. Smoking, previous chemotherapy treatment, and exposure to radiation may affect the risk of adult AML.